Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.
Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab.
'The challenge will be making sure its efficacy is high.' 'If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.'
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
I do think a younger population structure is an advantage against this virus, but there are other important factors such as the capacity of the healthcare system," says Dr Jennifer Dowd, associate professor of demography and population health, University of Oxford.
Economist and author Devaki Jain mourns the loss of her good friend, Girish Karnad.
Buttery papparadelle buried under a wild mushroom sauce and topped with shavings of fresh Parmesan cheese is a meal made in heaven.
A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.
'They say 'a picture paints a thousand words', so seeing Rishi Sunak PM at the door of Number 10 can never be taken from us.'' 'It is a symbol that will go down in the history books.' 'It is the very embodiment of me saying to my boys, "You can be who you want to be",' notes James Salins in this must-read feature.
Here's a fun quiz to test your knowledge.
'I'm now living under threat, but life has to go on because as a soldier, you can't run away from it.'
There was speculation that a one-time special Covid-19 cess would be imposed and that it would raise an estimated Rs 18,000 crore.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
Dispatch of the vaccine is likely to start by early Tuesday morning, sources said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210.
'A patient visits for any other treatment, but a routine Covid test finds him to be positive.' 'Not only are they, but their whole family is also coming out to be positive.'
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus.
During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.
The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.
'No matter how much the political pressure is, I cannot say I will bring the Moon for you tomorrow!'
Amit and Chandan from the Education UK team, British Council, hosted a chat with Get Ahead readers on May 15. The transcript.
A Chennai-based man has demanded a compensation of Rs 5 crore from the SII after his health worsened allegedly after volunteering for the clinical trials for a COVID-19 vaccine.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
The technical advisory group will now meet on November 3 for a final assessment.
Replying to a question at a press conference in New Delhi, Union Health Secretary Rajesh Bhushan said, "At many places in the world, more than one vaccine are being administered, but presently, in no country, vaccine recipients have the option of choosing the shots."
As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.
PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.
The wholesale price-based inflation shot up to an all-time high of 10.49 per cent in April, on rising prices of crude oil and manufactured items. Also, a low base of April last year contributed to the spike in inflation in April 2021. The WPI inflation was 7.39 per cent in March 2021, and (-) 1.57 per cent in April 2020. This is the fourth straight month of uptick seen in the wholesale price index (WPI)-based inflation.
There are a number of trial sites across both Mumbai and Pune that we have shortlisted, as these cities have many hotspots, which will help us understand the efficacy of the vaccine, the company's chief executive Adar Poonawalla said.
The volunteer said he had also volunteered 10 years ago for clinical trials for a vaccine against the H1N1 (swine flu) virus.
India will be within its rights to initiate reciprocal measures if the UK does not address concerns over the new travel rules relating to COVID-19 vaccine certification, foreign secretary Harsh Vardhan Shringla said on Tuesday describing the policy as "discriminatory".
The comments by a spokesperson in the British High Commission in New Delhi came amid concerns in India over the latest Covid-related travel restrictions announced by the UK.
On Tuesday, Rao said there was a possibility of the PM's visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.
SII's CEO Adar Poonawalla took to Twitter to announce the "philanthropic" gesture.
'Is China's intention not clear?' 'Do we still think that if we are nice to China, it will be good to us?'
Four students from Oxford, including one from India, have released a study guide that will help lakhs of students aged between 12 and 18 learn English, Chemistry and Math at home.
The Centre on April 19 had announced a ''liberalised'' policy, making all above 18 years of age eligible to get vaccinated from May 1. It has also allowed state governments and private hospitals to purchase vaccines from manufacturers.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said vaccine effectiveness will be seen only after 14 days.
Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances